Current Residents

Learn more about the current residents of Lab2Launch

Introducing the Inaugural Cohort of Lab2Launch Residents

We are thrilled to announce the first resident-startups of Lab2Launch, a new incubator at Emory University that enables early-stage biotech companies to develop or commercialize Emory IP. The companies that are moving to Lab2Launch are pushing the boundary of science and span a broad spectrum of biomedical innovation areas, including therapeutics, vaccine development and imaging.

Learn more about our initial seven companies below:

Cambium Therapeutics for cancer

This is the Cambium logo

Camerad Point-of-care patient photography integrated with medical imaging (Diagnostic)

This is the logo for Camerad

Emtherapro Diagnosis and treatment of neurodegenerative diseases

This is the logo for Emtherapro

MIGRA Therapeutics Drug delivery platforms for targeted therapy of drug-resistant cancers

This is the logo for MIGRA

OncoSpherix Small molecules targeting various forms of cancers

This is the logo for OncoSpherix

Pneumotactix Development of therapeutic enzymes against bacterial pathogens

This is the logo for PneumotaciX

PreClinico Pre-clinical drug efficacy testing for pulmonary fibrosis

This is the logo for Preclinico

 

Lab2Launch is currently vetting new applicants for residency. If you would like to learn more about the program and the application process, visit our incubator page.